In this issue:
Risk of relapse or progression after ASCT
Therapeutic regimens for older patients with newly diagnosed HL
Patients with DS 4 score at restaging PET require a biopsy prior to treatment intensification
BRAVE study finds BV-DHAP to be an effective salvage regimen for RR cHL
A simplified international prognostic score (IPS-3)
Is radiotherapy after chemotherapy necessary in stage I-IIA cHL?
Risk for bleomycin pulmonary toxicity increases with age over 50
Ten-year survival outcomes for patients with early stage cHL
Depression and anxiety in HL patients
Improved survival in HL patients with mediastinal bulk
Please login below to download this issue (PDF)